SecurityBBU / Brookfield Business Partners L.P. (G16234109)
Institutional Owners88 (5 N-Q Owners)
Institutional Shares43,498,273 (ex. N-Q)
Institutional Value$ 1,504,215,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

Brookfield Business Partners L.P. (NYSE:BBU) has 88 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 43,498,273 shares. Largest shareholders include Brookfield Asset Management Inc., Royal Bank Of Canada, CIBC Asset Management Inc, Partners Value Investments LP, Bank Of Montreal /can/, Manufacturers Life Insurance Company, The, Sentry Investments Corp., Vertex One Asset Management Inc., Principal Financial Group Inc, and Acadian Asset Management Llc.

Brookfield Business Partners L.P. (NYSE:BBU) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.


File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-02-14 13F-HR MORGAN STANLEY 71,963 67,116 -6.74 2,134 2,317 8.58
2017-10-27 N-Q Trust For Professional Managers (see advisory)
2018-02-14 13F-HR SOROS FUND MANAGEMENT LLC 210,769 7,276
2018-02-13 13F-HR Evercore Wealth Management, LLC 72 117 62.50 2 4 100.00
2018-02-14 13F-HR Glen Harbor Capital Management LLC 192 192 0.00 6 7 16.67
2018-02-09 13F-HR MARKEL CORP 101,594 101,594 0.00 3,012 3,507 16.43
2018-04-20 13F-HR LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA 232 232 0.00 8 8 0.00
2018-02-02 13F-HR CIBC Asset Management Inc 2,135,736 2,761,472 29.30 63,164 95,501 51.20
2018-02-09 13F-HR Tower Research Capital LLC (TRC) 255 5,155 1,921.57 10 223 2,130.00
2018-02-13 13F-HR MACKENZIE FINANCIAL CORP 60,280 66,830 10.87 1,787 2,307 29.10
2018-02-09 13F-HR Connor, Clark & Lunn Investment Management Ltd. 0 9,777 0 338
2018-02-14 13F-HR ROYAL BANK OF CANADA 6,396,444 6,276,932 -1.87 189,654 216,678 14.25
2017-11-27 N-Q Alps Variable Investment Trust (see advisory)
2018-02-13 13F-HR Partners Value Investments LP 1,716,780 1,716,780 0.00 50,903 59,263 16.42
2018-02-20 13F-HR ENVESTNET ASSET MANAGEMENT INC 219 231 5.48 6 8 33.33
2018-02-02 13F-HR US BANCORP \DE\ 72 72 0.00 2 2 0.00
2018-04-20 13F-HR Steward Partners Investment Advisory, Llc 583 21
2018-02-08 13F-HR TORONTO DOMINION BANK 225,808 227,594 0.79 6,696 7,849 17.22
2018-02-12 13F-HR Atlantic Trust Group, LLC 37 1
2018-02-14 13F-HR UBS Group AG 2,671 2,159 -19.17 79 75 -5.06
2018-02-12 13F-HR CITIGROUP INC 99,992 92,025 -7.97 2,959 3,179 7.43
2018-02-13 13F-HR SCOTIA CAPITAL INC. 118,606 121,974 2.84 3,517 4,196 19.31
2018-02-14 13F-HR Tyers Asset Management LLC 264 264 0.00 8 9 12.50
2018-04-13 13F-HR Steinberg Global Asset Management 16,431 17,431 6.09 567 628 10.76
2018-02-15 13F-HR/A-1 BROOKFIELD ASSET MANAGEMENT INC. 24,784,250 24,784,250 0.00 734,853 855,552 16.42
2018-02-06 13F-HR Community Bank, N.A. 20 20 0.00 1 1 0.00
2018-02-13 13F-HR COMMONWEALTH BANK OF AUSTRALIA 5 5 0.00 0 0
2018-01-30 13F-HR Roble, Belko & Company, Inc 11 11 0.00 0 0
2018-04-09 13F-HR Polaris Wealth Advisers, LLC 30 1
2018-02-09 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 333 333 0.00 11 11 0.00
2018-02-07 13F-HR OPPENHEIMER ASSET MANAGEMENT INC. 1 0 -100.00 0 0
2018-02-22 13F-HR Elkfork Partners LLC 264 9
2018-02-20 13F-HR Pin Oak Investment Advisors Inc 47 2
2018-02-02 13F-HR TD ASSET MANAGEMENT INC 94,982 142,985 50.54 2,810 4,940 75.80
2018-02-08 13F-HR PineBridge Investments, L.P. 3,820 3,820 0.00 113 132 16.81
2018-02-05 13F-HR Veritas Investment Management (UK) Ltd 57 57 0.00 2 2 0.00
2018-02-28 13F-HR Paulson Wealth Management Inc. 4 0
2018-02-14 13F-HR 1832 Asset Management L.P. 228,352 186,623 -18.27 6,549 6,427 -1.86
2018-02-14 13F-HR NORTHERN TRUST CORP 18,423 23,046 25.09 546 796 45.79
2018-02-14 13F-HR DEUTSCHE BANK AG\ 115,359 223,422 93.68 3,419 7,711 125.53
2018-02-28 N-Q Morgan Stanley Institutional Fund Trust (see advisory)
2017-11-13 13F-HR Burgundy Asset Management Ltd. 806,993 0 -100.00 32,983 0 -100.00
2018-02-14 13F-HR BANK OF AMERICA CORP /DE/ 2,600 1,878 -27.77 77 65 -15.58
2018-04-12 13F-HR ACADIAN ASSET MANAGEMENT LLC 550,284 350,928 -36.23 19,010 12,642 -33.50
2018-02-14 13F-HR FIFTH THIRD BANCORP 317 317 0.00 9 11 22.22
2017-11-03 13F-HR/A-1 CANADA PENSION PLAN INVESTMENT BOARD 14,300 0 -100.00 386 0 -100.00
2017-10-24 13F-HR Mps Loria Financial Planners, Llc 3 0 -100.00 0 0
2017-11-13 13F-HR CAPTRUST FINANCIAL ADVISORS 45 0 -100.00 1 0 -100.00
2018-02-14 13F-HR/A-1 Taylor Hoffman Wealth Management 3 0
2018-02-09 13F-HR Waratah Capital Advisors Ltd. 255,394 193,593 -24.20 7,572 6,680 -11.78
2017-11-27 N-Q Kinetics Mutual Funds Inc (see advisory)
2018-02-14 13F-HR Bluefin Trading, LLC 37,000 0 -100.00 1,097 0 -100.00
2017-11-09 13F-HR Burt Wealth Advisors 40 1 1 0.00
2018-02-14 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 763 3,619 374.31 22 125 468.18
2018-02-14 13F-HR Flinton Capital Management LLC 336 336 0.00 10 12 20.00
2018-02-08 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 1,009,274 1,222,844 21.16 29,925 42,213 41.06
2018-02-12 13F-HR PRINCIPAL FINANCIAL GROUP INC 470,601 563,072 19.65 13,953 19,437 39.30
2018-02-14 13F-HR GOLDMAN SACHS GROUP INC 0 18,812 0 649
2018-02-01 13F-HR CIBC World Markets Inc. 150,720 163,306 8.35 4,469 5,637 26.14
2017-11-08 13F-HR BRONFMAN E.L. ROTHSCHILD, L.P. 2 2 0.00
2018-02-08 13F-HR WELLS FARGO & COMPANY/MN 4,946 4,897 -0.99 146 168 15.07
2018-02-14 13F-HR Advisor Group, Inc. 85 90 5.88 2 3 50.00
2018-02-14 13F-HR Sentry Investments Corp. 577,274 936,274 62.19 21,359 32,320 51.32
2018-02-13 13F-HR DAVIS SELECTED ADVISERS 13,307 13,307 0.00 395 459 16.20
2018-04-20 13F-HR FIRST MANHATTAN CO 72,258 71,201 -1.46 2,496 2,564 2.72
2017-11-07 13F-HR Russell Investments Group, Ltd. 17 0 -100.00 0 0
2018-02-12 13F-HR Ninepoint Partners Lp 20,000 0 -100.00 593 0 -100.00
2018-02-14 13F-HR RIVERHEAD CAPITAL MANAGEMENT LLC 300 300 0.00 9 10 11.11
2018-02-13 13F-HR BANK OF NOVA SCOTIA TRUST CO 272 0 -100.00 9 0 -100.00
2017-11-13 13F-HR Glassman Wealth Services 20 0 -100.00 1 0 -100.00
2018-02-13 13F-HR Hillsdale Investment Management Inc. 161,600 180,600 11.76 4,796 6,211 29.50
2018-03-14 13F-HR/A-1 CREDIT SUISSE AG/ 110,600 110,200 -0.36 3,279 3,804 16.01
2018-02-14 13F-HR Covington Capital Management 0 1
2018-02-13 13F-HR Partners Group Holding AG 110,100 110,100 0.00 3,252 3,802 16.91
2018-03-28 13F-HR Chicago Partners Investment Group LLC 108 108 0.00 3 4 33.33
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ 1,218,750 1,258,444 3.26 42,072 45,317 7.71
2018-02-14 13F-HR Invesco Ltd. 25,106 34,328 36.73 744 1,185 59.27
2018-02-06 13F-HR Fusion Family Wealth LLC 1 1 0.00 1 1 0.00
2017-11-22 N-Q COLLEGE RETIREMENT EQUITIES FUND (see advisory)
2018-01-19 13F-HR Bartlett & Co. LLC 36 36 0.00 1 1 0.00
2018-02-13 13F-HR Renaissance Technologies LLC 83,065 193,300 132.71 2,464 6,675 170.90
2018-01-22 13F-HR Oakworth Capital, Inc. 85 60 -29.41 3 2 -33.33
2018-02-05 13F-HR Mascoma Wealth Management LLC 1 1 0.00 0 0
2018-02-13 13F-HR Jarislowsky, Fraser Ltd 8,258 8,276 0.22 244 285 16.80
2018-02-13 13F-HR JP Morgan Chase & Co 245 1,028 319.59 7 36 414.29
2018-01-26 13F-HR K.J. Harrison & Partners Inc 20,000 36,000 80.00 591 1,245 110.66
2018-02-07 13F-HR WHITTIER TRUST CO 128 128 0.00 4 4 0.00
2018-02-09 13F-HR Fiera Capital Corp 43,207 41,311 -4.39 1,281 1,428 11.48
2018-02-14 13F-HR Horizon Kinetics LLC 13,700 11,659 -14.90 406 402 -0.99
2018-01-31 13F-HR Resources Investment Advisors, Inc. 17 17 0.00 1 1 0.00
2018-02-14 13F-HR VERTEX ONE ASSET MANAGEMENT INC. 765,780 691,180 -9.74 22,708 23,804 4.83
2018-02-02 13F-HR SMITHFIELD TRUST CO 35 0 -100.00 1 0 -100.00
2018-02-14 13F-HR Neuburgh Advisers LLC 408 408 0.00 12 14 16.67
2018-02-07 13F-HR Financial Advantage, Inc. 9 0 -100.00 0 0
2018-02-14 13F-HR D. E. Shaw & Co., Inc. 27,700 953
2018-02-14 13F-HR PORTLAND INVESTMENT COUNSEL INC. 11,285 10,465 -7.27 298 361 21.14
2018-01-24 13F-HR IFP Advisors, Inc 6 0 -100.00 0 0
2018-02-13 13F-HR Parallel Advisors, LLC 17 17 0.00 1 1 0.00
2018-02-09 13F-HR/A-1 PUBLIC SECTOR PENSION INVESTMENT BOARD 478,880 193,775 -59.54 14,167 6,695 -52.74
2018-02-14 13F-HR Parallax Volatility Advisers, L.P. 83 83 0.00 2 3 50.00
2018-02-09 13F-HR BlackRock Inc. 18 18 0.00 1 1 0.00

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.

Limitations:

  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( BBU / Brookfield Business Partners L.P. ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: G16234109